YD
YD Bio Limited Ordinary Shares (YDES)
NASDAQ·Healthcare·Biotechnology
$3.94
+1.09%
Mkt Cap $141.66M
No analyst coverage available
We don't have analyst ratings or price target data for YD Bio Limited Ordinary Shares yet. Coverage gaps are common for sub-$1B market caps and recently-listed names.